Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Sunday, December 22, 2024

Chitosan-Based Nanocapsules as a Delivery System of Hydrophobic Carnosic Acid, A Model Neuroprotective Drug

I can't tell if this worked at all. What was the expected intervention result? Your mentors and senior researchers need to do a better job at describing the whole point of research.

 Chitosan-Based Nanocapsules as a Delivery System of Hydrophobic Carnosic Acid, A Model Neuroprotective Drug


Joanna Odrobińska-Baliś
1 , Magdalena Procner 1,2 , Kinga Krużel 1 , Magdalena Regulska 2 ,
Monika Leśkiewicz 2 , Dorota Duraczyńska
1 , Szczepan Zapotoczny 3 , Władysław Lasoń 2 ,
Krzysztof Szczepanowicz
1
1 Jerzy Haber Institute of Catalysis and Surface Chemistry, Polish Academy of Sciences, Krakow, Poland; 2 Maj Institute of Pharmacology Polish
Academy of Science, Krakow, Poland; 3 Faculty of Chemistry, Jagiellonian University, Krakow, Poland

Correspondence: Joanna Odrobińska-Baliś, Jerzy Haber Institute of Catalysis and Surface Chemistry, Polish Academy of Sciences, Niezpominajek 8,
Krakow, 30-239, Poland, Tel +48 12 6395128, Email joanna.odrobinska-balis@ikifp.edu.pl


Introduction: 

Since the population of Europe is rapidly aging, the number of cases of neurodegenerative diseases sharply increases. One of the most significant limitations of current neurodegenerative disease treatment is the inefficient delivery of neuroprotective drugs to the affected part of the brain. One of the promising methods to improve the pharmacokinetic and pharmacodynamic properties of antioxidants is their encapsulation in nanocarriers.

Materials and Methods: 

Encapsulation of carnosic acid into a chitosan-based nanoparticle system with ultrasound-assisted
emulsification process was developed. The physicochemical properties (size, stability, concentration of nanoparticles) of obtained nanocapsules were analyzed. Also, the cytotoxicity and neuroprotective effect in SH-SY5Y cells exposed to toxic concentration of H 2 O2 of the obtained nanoparticles were evaluated in vitro.

Results and Discussion: 

The capsules with diameters between 90 and 150 nm and long-term stability were obtained. Cytotoxicity tests of empty capsules indicate that observed toxic effects were concentration dependent and lower concentrations (dilution above 500×) can be considered as safe for tested cells. Our study also indicates that encapsulation of carnosic acid decreased the cytotoxicity
of empty nanocapsules and can efficiently protect SH-SY5Y cells from factors causing cell destruction. In addition, the neuroprotective efficacy of carnosic acid loaded nanocapsules was also demonstrated in SH-SY5Y cells exposed to toxic concentration of H2 O 2.
The designed nanoparticles appear to possess sufficient biocompatibility to deserve their further evaluation in in vivo models.

Keywords: polysaccharide nanocapsules, modified chitosan, carnosic acid, neuroprotection

No comments:

Post a Comment